W. R. Grace & Company Introduces Disposable Purification Solution To Lower Cost And Accelerate Drug Development For Biotech
3/24/2014 9:36:19 AM
COLUMBIA, Md.--(BUSINESS WIRE)--W. R. Grace & Co. (NYSE: GRA) has introduced ProVance™ pre-packed columns, a portfolio of products for cost-effective purification of biologic drugs, specifically monoclonal antibodies (mAbs). Monoclonal antibodies are key therapeutic agents used to treat rheumatoid arthritis, cancer and other diseases. Currently in the U.S., mAbs constitute the single largest biologics product category in the clinical development pipeline. Purification of these agents is a critical step in drug development.
Help employers find you! Check out all the jobs and post your resume.
comments powered by